These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31777768)

  • 1. Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles.
    O'Dea LSL; MacDougall J; Alexander VJ; Digenio A; Hubbard B; Arca M; Moriarty PM; Kastelein JJP; Bruckert E; Soran H; Witztum JL; Hegele RA; Gaudet D
    J Endocr Soc; 2019 Dec; 3(12):2397-2410. PubMed ID: 31777768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic.
    Rioja J; Ariza MJ; García-Casares N; Coca-Prieto I; Arrobas T; Muñiz-Grijalvo O; Mangas A; Ibarretxe D; Sánchez-Chaparro MÁ; Valdivielso P
    Eur J Clin Invest; 2020 Dec; 50(12):e13345. PubMed ID: 32649781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    Paquette M; Amyot J; Fantino M; Baass A; Bernard S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia.
    Paquette M; Bernard S; Hegele RA; Baass A
    Atherosclerosis; 2019 Apr; 283():137-142. PubMed ID: 30655019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial.
    Rosenson RS; Gaudet D; Ballantyne CM; Baum SJ; Bergeron J; Kershaw EE; Moriarty PM; Rubba P; Whitcomb DC; Banerjee P; Gewitz A; Gonzaga-Jauregui C; McGinniss J; Ponda MP; Pordy R; Zhao J; Rader DJ
    Nat Med; 2023 Mar; 29(3):729-737. PubMed ID: 36879129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
    Falko JM
    Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia.
    D'Erasmo L; Gallo A; Di Costanzo A; Bruckert E; Arca M
    Expert Opin Pharmacother; 2020 Oct; 21(14):1675-1684. PubMed ID: 32646313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
    Blom DJ; O'Dea L; Digenio A; Alexander VJ; Karwatowska-Prokopczuk E; Williams KR; Hemphill L; Muñiz-Grijalvo O; Santos RD; Baum S; Witztum JL
    J Clin Lipidol; 2018; 12(5):1234-1243.e5. PubMed ID: 30318066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
    Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
    J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia.
    Baass A; Paquette M; Bernard S; Hegele RA
    J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of familial chylomicronemia syndrome in Canadian patients.
    Gaudet D; Stevenson M; Komari N; Trentin G; Crowson C; Hadker N; Bernard S
    Lipids Health Dis; 2020 Jun; 19(1):120. PubMed ID: 32487261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
    Gallo A; Béliard S; D'Erasmo L; Bruckert E
    Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chylomicronemia syndrome: Familial or not?
    Warden BA; Minnier J; Duell PB; Fazio S; Shapiro MD
    J Clin Lipidol; 2020; 14(2):201-206. PubMed ID: 32107181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes.
    D'Erasmo L; Di Costanzo A; Cassandra F; Minicocci I; Polito L; Montali A; Ceci F; Arca M
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2531-2541. PubMed ID: 31619059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volanesorsen for treatment of familial chylomicronemia syndrome.
    Lazarte J; Hegele RA
    Expert Rev Cardiovasc Ther; 2021 Aug; 19(8):685-693. PubMed ID: 34261380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia.
    Maltais M; Brisson D; Gaudet D
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33572376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia.
    Tremblay K; Gaudet D; Khoury E; Brisson D
    J Endocr Soc; 2020 Jun; 4(6):bvaa056. PubMed ID: 32537545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of a Fat-Restricted Diet in Four Patients with Familial Chylomicronemia Syndrome: A Long-Term Follow-Up Study.
    Thajer A; Skacel G; de Gier C; Greber-Platzer S
    Children (Basel); 2021 Nov; 8(11):. PubMed ID: 34828789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
    Davidson M; Stevenson M; Hsieh A; Ahmad Z; Roeters van Lennep J; Crowson C; Witztum JL
    J Clin Lipidol; 2018; 12(4):898-907.e2. PubMed ID: 29784572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Update on the Chylomicronemia Syndrome.
    Goldberg RB; Chait A
    Front Endocrinol (Lausanne); 2020; 11():593931. PubMed ID: 33193106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.